HSBC Holdings’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.04M | Sell |
14,283
-14,385
| -50% | -$1.05M | ﹤0.01% | 1372 |
|
|
2025
Q1 | $3.01M | Buy |
28,668
+1,253
| +5% | +$131K | ﹤0.01% | 1009 |
|
|
2024
Q4 | $1.38M | Sell |
27,415
-26,988
| -50% | -$1.36M | ﹤0.01% | 1314 |
|
|
2024
Q3 | $2.56M | Sell |
54,403
-53,963
| -50% | -$2.54M | ﹤0.01% | 1075 |
|
|
2024
Q2 | $3.48M | Buy |
108,366
+27,785
| +34% | +$892K | ﹤0.01% | 980 |
|
|
2024
Q1 | $2.03M | Buy |
80,581
+34,152
| +74% | +$860K | ﹤0.01% | 1166 |
|
|
2023
Q4 | $1.51M | Buy |
46,429
+20,360
| +78% | +$663K | ﹤0.01% | 1264 |
|
|
2023
Q3 | $707K | Buy |
26,069
+3,993
| +18% | +$108K | ﹤0.01% | 1419 |
|
|
2023
Q2 | $492K | Sell |
22,076
-659,002
| -97% | -$14.7M | ﹤0.01% | 1579 |
|
|
2023
Q1 | $14.8M | Buy |
681,078
+632,443
| +1,300% | +$13.7M | 0.02% | 625 |
|
|
2022
Q4 | $984K | Buy |
48,635
+15,153
| +45% | +$306K | ﹤0.01% | 1578 |
|
|
2022
Q3 | $872K | Buy |
33,482
+15,355
| +85% | +$400K | ﹤0.01% | 1518 |
|
|
2022
Q2 | $434K | Sell |
18,127
-3,358
| -16% | -$80.4K | ﹤0.01% | 2022 |
|
|
2022
Q1 | $484K | Sell |
21,485
-3,555
| -14% | -$80.1K | ﹤0.01% | 2092 |
|
|
2021
Q4 | $498K | Buy |
25,040
+9,042
| +57% | +$180K | ﹤0.01% | 2015 |
|
|
2021
Q3 | $316K | Sell |
15,998
-6,743
| -30% | -$133K | ﹤0.01% | 2060 |
|
|
2021
Q2 | $503K | Buy |
22,741
+7,065
| +45% | +$156K | ﹤0.01% | 1770 |
|
|
2021
Q1 | $376K | Buy |
15,676
+1,412
| +10% | +$33.9K | ﹤0.01% | 1823 |
|
|
2020
Q4 | $373K | Buy |
+14,264
| New | +$373K | ﹤0.01% | 2000 |
|
|
2019
Q4 | – | Sell |
-18,634
| Closed | -$263K | – | 2470 |
|
|
2019
Q3 | $263K | Buy |
+18,634
| New | +$263K | ﹤0.01% | 2128 |
|
|
2017
Q1 | – | Sell |
-12,868
| Closed | -$93K | – | 1763 |
|
|
2016
Q4 | $93K | Buy |
+12,868
| New | +$93K | ﹤0.01% | 2174 |
|